<DOC>
	<DOCNO>NCT00447460</DOCNO>
	<brief_summary>Clinical trial base use new therapeutic strategy ( MSC infusion ) treatment patient develop GVHD refractory usual therapeutic measure undergo allogenic hematopoietic stem cell transplant .</brief_summary>
	<brief_title>Treatment Refractory ( Acute Chronic ) Graft-Versus-Host Disease Infusion Expanded in-Vitro Allogenic Mesenchymal Stem Cell</brief_title>
	<detailed_description>This multicenter , single dose study allogenic mesenchymal stem cell ( 1-2 x 10^6 MSC/Kg recipient´s bodyweight ) . MSC infuse , central venous catheter , patient diagnose GVHD refractory first-line subsequent treatment . All patient receive treatment . MSC suspension obtain bone marrow aspiration family donor expand in-vitro specific culture medium autologous donor´s serum animal-derived product .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Patients hematological malignancy undergo allogenic hematopoietic stem cell transplant diagnose GVHD refractory usual treatment . Adequate cardiac function evidence uncontrolled high blood pressure , congestive heart failure , angina pectoris , acute myocardial infarction within 6 month prior process . Adequate pulmonary function evidence chronic obstructive severe restrictive pulmonary disease . Patients age 18 65 year . Signature informed consent form require do patient donor . Patients whose hematopathology control transplant progress . Patients bacterial , viral fungal infection control adequate treatment . Patients inadequate cardiac pulmonary function . Patients , investigator´s point view , situation tolerate treatment . Patients require donor ( HLAidentical sibling donor HLAidentical sibling donor ) . Pregnant female childbearing potential adequate contraceptive measure . Patients &lt; 18 &gt; 65 year . Patients sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Graft-vs-host disease ( GVHD )</keyword>
	<keyword>Mesenchymal stem cell ( MSC )</keyword>
	<keyword>Allogeneic hematopoietic stem cell transplant</keyword>
	<keyword>Allotransplant</keyword>
	<keyword>Allogenic</keyword>
	<keyword>Refractory</keyword>
	<keyword>CSM/EICH2005</keyword>
</DOC>